Adenovirus infection results in the suppression of cellular protein synthesis, but the mechanism has not been established. In this report we demonstrate that the shut-off of cellular protein synthesis by adenovirus is prevented in cells by treatment with the drug 2-aminopurine. Treatment with 2-aminopurine is shown to prevent suppression of cellular translation without disrupting the normal viral block in the transport of cellular mRNAs from the nucleus to the cytoplasm. We show that viral suppression of cellular protein synthesis occurs concomitant with activation of the interferon-induced double-stranded RNA-activated inhibitor (DAI), a protein kinase, and phosphorylation of the a subunit of eukaryotic initiation factor 2 (eTF-2a), but that prevention of host cell shut-off by 2-aminopurine occurs without a decrease in kinase activity or a dephosphorylation of eTF-2a. Results are presented that indicate that activation of DAI kinase and phosphorylation of eIF-2a may be required but are not sufficient to achieve inhibition of cellular protein synthesis during adenovirus infection. We suggest that other events, in particular the modification of additional initiation factors, are likely involved in viral inhibition of cellular translation.
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Adenoviruses (Ad) mediate a complex series of metabolic alterations at late times after infection, suppressing fundamental host processes such as the continued transport and translation of cellular mRNAs while promoting the translation of late viral messages (1, 2). The mechanism by which Ad dominates cellular protein synthesis is only poorly understood. However, recent progress by O'Malley et al. (3) has demonstrated that Ad cannot inhibit host protein synthesis in cells that express very low levels of the double-stranded RNA-activated inhibitor (DAI), a protein kinase. DAI kinase is thought to function in the antiviral response because it is induced by interferon. More importantly, its activation after infection by a variety of viruses results in inhibition of translation through the phosphorylation of the a subunit of eukaryotic initiation factor 2 (eIF-2a; reviewed in ref. 4 ). However, wild-type (wt) Ad is immune to the activation of DAI kinase (5) , whereas Ad mutant strain H5dl331 (dl331), which is unable to synthesize an abundant small virusassociated I transcript called VAI RNA, evokes an enormous activation of DAI kinase and results in the global inhibition of both viral and cellular protein synthesis (6) . VAI RNA may counter the host antiviral response during Ad infection because it binds to DAI kinase (7, 8) , blocks its activation (9, 10) , and preserves the function of eIF-2 (10, 11). Nevertheless, partial activation of DAI and phosphorylation of eIF-2a molecules occur in some cell lines infected by wt Ad (3, 12) .
This report investigates the suppression of host cell protein synthesis by Ad and the role for limited activation of DAI kinase and phosphorylation of eIF-2a. We demonstrate that the drug 2-aminopurine (2AP), an agent that inhibits the in vitro activity of a number of protein kinases, including DAI (13, 14) , prevents the normal shut-off of cellular translation induced by wt Ad as well as the global inhibition of protein synthesis observed in mutant Ad d1331-infected cells. Since 2AP did not prevent the activation of DAI kinase and the phosphorylation of eIF-2a that mostly occurs after viral infection, our results indicate that these changes are not sufficient for suppression of host cell protein synthesis. Instead, we suggest that the inhibition of cellular protein synthesis during Ad infection is mediated by an additional event, very likely the modification of a second initiation factor, which may be prevented by the action of 2AP.
MATERIALS AND METHODS
Viruses and Cells. wt Ad type 5 (Ad5) strain H5wt300 (wt300) is a plaque-purified stock obtained from H. Ginsberg. Mutant Ad d1331 contains a deletion within the intragenic control region of the VAI gene and therefore does not produce VAI RNA (6) . 293 cells are a human embryonic kidney cell line transformed with the El region of Ad5 (15 (20) . Analysis of eIF-2a Phosphorylation. Preparation of extracts and in vitro phosphorylation assays (21) have been described (10) . For in vivo analysis of eIF-2a, whole-cell proteins were resolved by isoelectric focusing gels as described by Scorsone et al. (22) incorporating the modifications of O'Neill and Racaniello (23) . Cell lysis in urea/Ampholine mixture, prefocusing of gels, and focusing of polypeptides were carried out as described (23) . Proteins were transferred to nitrocellulose for 15 hr at 400 mA as described (22) . Immunoblotting was performed without glutaraldehyde fixation by using a monoclonal antibody to eIF-2a (a gift from E. Henshaw, University of Rochester) followed by 1251I-labeled goat antimouse sera (Amersham). Densitometry of autoradiograms was performed with an LKB Ultrospec II. (6, (9) (10) (11) (12) . To study the effects of 2AP on translation shut-off by Ad, cells were exposed to the drug after infection and Proc. Natl. Acad. Sci. USA 87 (1990) absence of 2AP (Fig. 2) It was determined whether the maintenance of cellular translation by treatment with 2AP is related to changes in the cytoplasmic levels of either viral or cellular mRNAs. Northern analysis was used to determine the steady-state levels of a number of different cytoplasmic mRNAs at late times after infection with wt300 virus. Levels of cellular and early viral mRNAs remained unchanged during treatment with 2AP (Fig. 3) , despite a large increase in the synthesis of new polypeptides. Transcripts analyzed included mRNAs for actin and Ad E2A (Fig. 3) Cells were labeled with [3H]uridine 18 hr after infection, and RNAs were prepared as described. Levels of newly synthesized and transported cytoplasmic 18S rRNA were determined by electrophoresis in formaldehyde/agarose gels followed by fluorography and densitometry of autoradiograms. Cytoplasmic levels of newly synthesized cellular mRNAs were determined by exhaustive hybridization of 10W cpm of poly(A)+ RNA to filters containing AdS DNA as described (20) . All values are expressed as the ratio of test sample to uninfected control. Ad-inf., Ad-infected; Mock, uninfected.
RESULTS
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formed to investigate the correlation between suppression of host protein synthesis and the activity of DAI kinase and phosphorylation state of eIF-2a. Extracts were prepared from 293 cells 18 hr after infection with wt300 or d1331 Ad, as well as from duplicate plates treated with 2AP. Although both eIF-2a and eIF-2,B subunits are substrates for phosphorylation by different kinases, only phosphorylation of eIF-2a is regulated and alters eIF-2 activity (26, 27) . As shown previously (3, 5) , DAI kinase activity was found to be increased 2-to 3-fold by infection with high multiplicities of wt300 virus and -20 fold by infection with mutant d1331, in comparison with uninfected cell extracts (Fig. 4) . Curiously, treatment with 2AP was not found to alter the activity of DAI kinase in wt300 virusinfected cell extracts, and only reduced by half the large activation of DAI in cells infected with d1331. The levels of eIF-2a phosphorylation found in infected cells after treatment with 2AP, particularly in those infected with d1331 virus, clearly should result in the global inhibition of protein synthesis and are inconsistent with the ongoing translation of both viral and cellular mRNAs. In reticulocyte lysates, for example, a 3-fold increase in DAI kinase activity generally reduces protein synthesis (28), whereas similar increases were observed in translationally competent wt300 virusinfected cells. Therefore, to further characterize the mechanism for suppression of cellular protein synthesis by Ad, we measured the level of eIF-2a phosphorylation in vivo.
Total cell proteins were resolved in isoelectric focusing gels, transferred to nitrocellulose, and immunoblotted with a monoclonal antibody directed against eIF-2a (Fig. 5) . The phosphorylated form of eIF-2a is more acidic and migrated slightly ahead of the unmodified polypeptide (22) . In uninfected cells, typically only 5-10% of eIF-2a molecules were found to be phosphorylated, in good agreement with other Whole-cell lysates were prepared, and polypeptides were resolved in isoelectric focusing gels as described (22, 23) . Proteins were transferred to nitrocellulose and immunoblotted with a mouse monoclonal antibody to eIF-2a. Coelectrophoresis of purified eIF-2 was used to identify the unphosphorylated (a) and phosphorylated [a(P)] forms of eIF-2a (not shown). The faint second acidic band in the d1331 lanes occurs after excessive phosphorylation at a second site in eIF-2a. Autoradiograms were quantitated by densitometry.
published reports (3, 22, 23) . At late times after infection, -25% of eIF-2a was phosphorylated in wt300 virus-infected cells and 90% in mutant d1331-infected cells. Treatment with 2AP failed to reduce the level of eIF-2a phosphorylation in wt300 virus-infected cells and only reduced by half the extensive phosphorylation in d1331 virus-infected cells. Thus, these data confirm the results from in vitro phosphorylation assays and demonstrate that the activation of DAI kinase and phosphorylation of eIF-2a are not sufficient for the suppression of cellular protein synthesis during Ad infection.
DISCUSSION
We have demonstrated that suppression of cellular protein synthesis by Ad is prevented by treatment with the drug 2AP, but that the role of DAI kinase and phosphorylation of eIF-2a are unclear. Cells normally sensitive to translation shut-offby Ad can be made resistant by treatment with 2AP (Fig. 1) ; however, the site of action for 2AP in this system must now be determined. Although this drug has been shown to inhibit the activity or activation of DAI kinase in vitro (13, 14) , it also has been shown to prevent the transcriptional induction of genes normally responsive to a interferon and doublestranded RNA (29) (30) (31) (32) . Thus, although cells deficient in induction of DAI kinase are resistant to translation shut-off by Ad (3), other genes are also likely to be involved.
Treatment with 2AP had only a modest effect on viral growth (Fig. 2) , reducing final virus yields by factors of 2-3. Therefore, we can exclude defects in viral replication as the basis for recovery of host translation mediated by 2AP. Furthermore, 2AP was not noticeably toxic to cells during the exposure period, as observed by others as well (30) (31) (32) (33) . Finally, treatment with 2AP did not appear to alter the cytoplasmic level of cellular mRNAs or to reverse the normal viral block to their transport ( Fig. 3 (34) (35) (36) .
The demonstration that 2AP acts as an inhibitor of protein kinases in vitro (13, 14) , rescued protein synthesis in d1331 virus-infected cells, and prevented the suppression of host mRNA translation by wt300 Ad, would suggest that the drug acts by inhibiting activation of DAI kinase. Therefore, it was surprising to find that 2AP had no detectable effect on DAI kinase activity in wt300-infected cells and only reduced by about half the massive phosphorylation of eIF-2a in d1331-infected cells (Figs. 4 and 5) . Previous studies have shown that 2AP enhanced translation of plasmid-derived mRNAs (33) , which were apparently restricted by activation of DAI kinase (37) , although the direct effect of 2AP on eIF-2a phosphorylation was not determined in vivo. However, it has recently been shown that in poliovirus-infected cells treatment with 2AP also failed to reduce eIF-2a phosphorylation (23) . Consistent with these observations, 2AP was found to act early in the interferon pathway by preventing the induction of interferon but not the subsequent activation of the double-stranded RNA-dependent antiviral enzymes (31) .
It is now clear that seemingly inhibitory levels of DAI kinase activity and eIF-2a phosphorylation persist in a number of systems without the global inhibition of protein synthesis, such as in Ad d1331-infected cells treated with 2AP (this report) or coinfected with influenza virus (38) , cells infected with high multiplicities of wt Ad (ref. 3; this report), poliovirus-infected cells (23, 39) , cell-free translation systems (28) , and cells transfected with a variety of plasmids (37) . It has been proposed that phosphorylation of eIF-2a may contribute to mRNA specificity in translational control (37 Finally, these results suggest a potential mechanism by which Ad may suppress cellular protein synthesis. Perhaps Ad infection results in the modification of other translation factors, possibly through a pathway activated by doublestranded RNA or viral gene products. The activity of many initiation factors is regulated by their state ofphosphorylation during heat-shock, stress, and other physiologically relevant processes (43) . We have previously demonstrated that late Ad mRNAs, which contain a common 5' noncoding region called the tripartite leader, translate without a requirement for initiation factor eIF-4F (16) . Nevertheless, the function of the tripartite leader during the viral life cycle is unclear, since its translation effects do not extend to all mRNAs to which it is attached (44, 45) , and mRNAs that lack it are still translated in late viral-infected cells. However, given that the activity of eIF-4F potentially correlates with the phosphorylation state of one of its subunits (46) 
